Dennis Crouch's Patently-O: 1 new topics, including “Federal Circuit Denies En Banc Request in BPCIA case” |
Federal Circuit Denies En Banc Request in BPCIA case Posted: 16 Oct 2015 07:59 AM PDT by Dennis Crouch Following the Federal Circuit’s first interpretation of the Biologics Price Competition and Innovation Act (“BPCIA”), neither the patentee (Amgen) nor the biosimilar applicant (Sandoz) were satisfied. Each petitioned separately for en banc rehearing and both petitions have now been denied in a per curium opinion. (Background from Andrew Williams at PatentDocs). Both parties will likely petition the Supreme Court for further interpretation of the “biologics patent dance” |
Posted: 16 Oct 2015 05:37 AM PDT Now that the USPTO has opened its Silicon Valley office, Santa Clara is offering its limited-time Michelle K. Lee Bobblehead. Enter to win here: http://law.scu.edu/high-tech-law-institute/uspto-director-michelle-k-lee-bobblehead-giveaway/ |
You are subscribed to email updates from Patently-O » Patent. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |
No comments:
Post a Comment